256 - Vaccines and Their Impact

Moderator(s)

• 

  Pia Pannaraj, MD, MPH

  Professor
  University of California San Diego
• KE

  Kathryn Edwards, MD

  Professor of Pediatrics Emerita
  Vanderbilt University Medical Center
  Nashville, TN, United States

Presentations:

• 1:45 PM – 2:00 PM US PT

  Immunogenicity and Safety of High-dose versus Double-dose Quadrivalent Inactivated Influenza Vaccine in Adult Kidney Transplant Recipients: A Randomized Controlled Trial
  

  Presenting Author: Thanachote Arayanumas, MD (he/him/his) – Faculty of Medicine Ramathibodi Hospital, Mahidol University

  Co-Author: Kobporn Boonnak, Ph.D. – Faculty of Medicine Siriraj Hospital, Mahidol University

  Co-Author: Surasak Kantachuvesiri, MD – Faculty of Medicine Ramathibody Hospital, Mahidol University

  Co-Author: Sarinya Boongird, MD – Faculty of Medicine Ramathibodi Hospital, Mahidol University

  Co-Author: Sasisopin Kiertiburanakul, MD MHS – Faculty of Medicine Ramathibodi Hospital

  Co-Author: Jackrapong Bruminhent, MD, FIDSA – Faculty of Medicine Ramathibodi Hospital, Mahidol University
• 2:00 PM – 2:15 PM US PT

  Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
  

  Presenting Author: Luca Tudor Giurgea, MD – National Institute of Allergy and Infectious Diseases

  Co-Author: Alison Han, MD, MS – National Institutes of Health

  Co-Author: Lindsay Czajkowski, MSN, NP-C – National Institute of Allergy and Infectious Diseases

  Co-Author: Holly Ann Baus, RN, MSN – National Institute of Allergy and Infectious Diseases

  Co-Author: Gregory Mak, MD, MPH – LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Kimberly Adao, RN, BSN – LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Ian Bellayr, PhD – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Adriana Cervantes-Medina, BS – National Institute of Allergy and Infectious Diseases

  Co-Author: Monica Gouzoulis, BS – LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Jenna Sherry, MS – LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Rani Athota, PhD – National Institute of Allergy and Infectious Diseases

  Co-Author: Viviane Callier, PhD – Frederick National Laboratory for Cancer Research

  Co-Author: Sally Hunsberger, PhD – National Institute of Allergy and Infectious Diseases

  Co-Author: Jaekeun Park, DVM, PhD – Department of Veterinary Medicine, VA-MD College of Veterinary Medicine, University of Maryland

  Co-Author: Jeffery Taubenberger, MD, PhD – National Institute of Allergy and Infectious Diseases

  Co-Author: Matthew J. Memoli, MD, MS – National Institute of Allergy and Infectious Diseases
• 2:15 PM – 2:30 PM US PT

  A Phase I, Multicenter, Randomized, Double-blind, Placebo-controlled Single Dose, Dose-ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of Orally Administered Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females ≥ 18 years Old and Their Breast-feeding Infants
  

  Presenting Author: Lam Nguyen, MD (she/her/hers) – Vaxart Inc

  Co-Author: Susan Greco, MD, MPH – Vaxart, Inc

  Co-Author: Becca A. Flitter, PhD, MPH – Vaxart Inc

  Co-Author: Molly Braun, PhD – Vaxart, Inc

  Co-Author: Nicholas D’Amato, MSc. – Vaxart

  Co-Author: Sean N. Tucker, PhD – Vaxart

  Co-Author: James F. Cummings, MD – VAXART

  Co-Author: Colin A. Lester, n/a – Vaxart, Inc.

  Co-Author: Darreann Carmela Hailey, MS – Vaxart, Inc.
• 2:30 PM – 2:45 PM US PT

  The Effect of Herpes Zoster Vaccination on New Diagnoses of Dementia: A Quasi-randomized Study in Australia
  

  Co-Author: Michael Pomirchy, PhD – Stanford University

  Co-Author: Christian Bommer, PhD – Stanford University

  Presenting Author: Pascal Geldsetzer, MD PhD MPH (he/him/his) – Stanford University
• 2:45 PM – 3:00 PM US PT

  Immunogenicity and Safety of BPZE1, an Intranasal Live Attenuated Pertussis Vaccine, Evaluated With and Without Tdap in Healthy Children 6 to 17 Years Old: A Phase 2b, Randomized, Active-Controlled Study
  

  Co-Author: Saul N. Faust, FRCPCH PhD (he/him/his) – University of Southampton and University Hospital Southampton NHS Foundation Trust

  Co-Author: Javier Céspedes, MD – Clinica San Agustin

  Co-Author: Lydiana Avila, MD – Instituto de Investigación de Ciencias Médicas

  Presenting Author: Gabriela Ivankovich-Escoto, MD – Metropolitano Research Institute

  Co-Author: Helen Marshall, MD – University of Adelaide

  Co-Author: Peter Richmond, MBBS – University of Western Australia School of Medicine, Perth’s Children Hospital

  Co-Author: Terry Nolan, MD, PhD (he/him/his) – The Peter Doherty Institute for Infection and Immunity, Murdoch Children’s Research Institute

  Co-Author: Jolanta Bernatoniene, FRCPCH PhD – University Hospitals Bristol & Weston NHS Foundation Trust, Bristol Royal Hospital For Children

  Co-Author: Srini Bandi, MD – Leicester Children's Hospital

  Co-Author: Anil Shenoy, FRCPCH – Bradford Royal Infirmary

  Co-Author: Lisa Weissfeld, PhD – WCG Clinical

  Co-Author: Wei Lang, PhD – WCG Clinical

  Co-Author: Camille Locht, PhD – Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017–CIIL - Centre for Infection and Immunity of Lille

  Co-Author: Vivek Samal, MD – ILiAD Biotechnologies

  Co-Author: Peter Goldstein, n/a – ILiAD Biotechnologies

  Co-Author: Ken Solovay, n/a – ILiAD Biotechnologies

  Co-Author: Keith Rubin, MD – ILiAD Biotechnologies

  Co-Author: Stephanie Noviello, MD, MPH – ILiAD Biotechnologies